Evidence map›Paper›PMID 28647695›Full record

ReviewCancer genomics & proteomics

The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.

Weidong Zhou, Lance A Liotta, Emanuel F Petricoin

Abstract readReview
In one paragraph

Review in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Mitoproteomics: Tackling Mitochondrial Dysfunction in Human Disease.Oxidative medicine and cellular longevity · 2018
    Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weidong ZhouCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, U.S.A. wzhou@gmu.edu.
Lance A LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, U.S.A.
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, U.S.A.

Funding

Microparticles for Directing Immune Cell TraffickingR21AI117425 · NIAID · GEORGE MASON UNIVERSITY · PI ESPINA, VIRGINIA ANNE, LIOTTA, LANCE ALLEN · 2015 to 2016
$418k
Microparticle Capture-Based Analysis of Lymph Node ProteomeR21AI099851 · NIAID · GEORGE MASON UNIVERSITY · PI ESPINA, VIRGINIA ANNE, LIOTTA, LANCE ALLEN · 2013 to 2014
$405k
NIAID NIH HHS R21 AI099851NIAID NIH HHS R21 AI117425
6 · The paper itself

Abstract

Compared to normal cells, cancer cells have a unique metabolism by performing lactic acid fermentation in the presence of oxygen, also known as the Warburg effect. Researchers have proposed several hypotheses to elucidate the phenomenon, but the mechanism is still an enigma. In this review, we discuss three typical models, such as "damaged mitochondria", "adaptation to hypoxia", and "cell proliferation requirement", as well as contributions from mass spectrometry analysis toward our understanding of the Warburg effect. Mass spectrometry analysis supports the "adaptation to hypoxia" model that cancer cells are using quasi-anaerobic fermentation to reduce oxygen consumption in vivo. We further propose that hypoxia is an early event and it plays a crucial role in carcinoma initiation and development.

Indexed as

AnimalsCell ProliferationHumansMass SpectrometryOxygenProteomicsOxygenCancer metabolismmass spectrometryreviewWarburg effect

Identifiers

PMID28647695
PMCPMC5572299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.